Mayo Clinic Doctor Says Mark Cuban’s Cost Plus Drugs is Bringing “Access” to U.S. Healthcare

 

Mark Cuban’s Cost Plus Drugs is making waves in the pharmacy market, gaining more than 1.2 million customers and selling over 1000 generic low-cost drugs at a fraction of the prescription price that Big Pharma puts on the marketplace. The big question now is whether the supply chain can fundamentally shift toward Cuban’s low-cost model as brand-name drugs resist the shift. Assistant Professor of Epidemiology for the Mayo Clinic College of Medicine at Mayo Clinic, Dr. Jose Medina-Inojosa, breaks down the ripple effects from the Cost Plus Drugs approach to drug product logistics.

Dr. Medina-Inojosa’s Thoughts

“Just to give you a little of context, as we all know, we are probably working in the best healthcare system of the world, but one of the major challenges that we have is access, and specifically prescription access is becoming a major problem in the United States. About 18 million people, about 7% of the whole United States, have a lot of trouble accessing medications and this company is probably gonna help some of the problems. They’re based in Dallas, they’re expanding access, they’re negotiating new deals with drug companies, getting access to generic medications that are about 85% cheaper. Talking about, to give you some example for some leukemia medications, it could take a drug from $2,500 to $14 at Mark Cuban’s Cost Plus Drugs, which is extremely exciting.

They’re also working with manufacturing their ordinary prescription medications in Dallas, and I think down the line they’re promising to continue to expand their deals and their reach over the next six or 12 months. So it’s not the major solution to fix all the problems, but I think it’s a really good step in the right direction. And I’m looking forward to see how it will help shape the face of healthcare and how it will help deliver access.”

Follow us on social media for the latest updates in B2B!

Image

Latest

career
The Power of Reinvention: How Debbie Crouse Crafted a Career Across Industries
October 29, 2025

As the modern workforce continues to evolve, conversations around balance, fulfillment, and flexibility are taking center stage. With hybrid work redefining expectations and career paths becoming less linear, professionals are asking deeper questions about what “success” really means. According to Gallup’s latest data, only 31% of U.S. employees were engaged at work in…

Read More
acceptance
Coaching Away the Imposter Voice: Transforming Self-Doubt into Self-Acceptance
October 28, 2025

Authenticity isn’t about perfection — it’s about having the courage to show up as your true self, even when self-doubt creeps in. Many of us wrestle with imposter syndrome, people-pleasing, and the fear of being seen, but real growth happens when we embrace vulnerability and learn to trust our own voice. By letting go of…

Read More
pillars
Discovering Your Guiding Pillars: Aligning Ambition with Wellbeing for a Purpose-Driven Career
October 28, 2025

Success without sacrifice—that’s what more leaders are striving for. As burnout rates climb among high-achieving professionals balancing leadership, entrepreneurship, and family, the question of how to build sustainable success without sacrificing health or identity has never been more timely. Gallup’s research shows that burnout is far from rare: roughly three-quarters of U.S. employees say…

Read More
HR Like a Boss
HR Like a Boss: Building Purpose-Driven, People-Focused, Profitable Teams
October 28, 2025

HR teams are navigating the tension between technology and empathy, discovering new ways to lead with purpose while keeping people at the heart of every transformation. Artificial intelligence, automation, and hybrid work models are rapidly reshaping workplace culture, pushing HR to evolve from administrative oversight to true strategic leadership. As a recent SHRM report…

Read More